You are here:

MS in the Media - 23 March 2018

Published on

17 – 23 March 2018

These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts

Stem cell study for people with highly active relapsing MS shows promising results

Preliminary data from an international stem cell study for people with highly active relapsing multiple sclerosis has reported that those having stem cell treatment had fewer relapses and improved disability levels.

Source: BBC
Source: Telegraph
Source: Independent
Source: Daily Mail
Source: The Sun

MS Trust link: Stem cell study for people with highly active relapsing MS shows promising results

Caroline Wyatt talks about stem cell treatment

BBC journalist Caroline Wyatt talks about her experience of having stem cell treatment in Mexico last year.

Source: BBC

MS Trust link: Stem cell therapy

Siponimod secondary progressive MS results published in Lancet

Results from a large clinical trial of siponimod for secondary progressive MS (SPMS) have been published in the Lancet. Those taking siponimod had a 21% reduced risk of progression.

Source: BBC
Source: Daily Mail
Source: Guardian
Source: Sun
Source: Novartis press release

MS Trust link: Siponimod trial results